Soft tissue repair · Foot & ankle
Excision or curettage of a bone cyst or benign tumor from the talus or calcaneus, with autograft harvested from the iliac crest or another donor site to fill the defect — graft harvest is included in the code.
Verified May 8, 2026 · 5 sources ↓
- Medicare
- $583.18
- Work RVU
- 7.72
- Global, days
- 90
- Region
- Foot & ankle
Documentation requirements
What must appear in the operative or office note to support the claim.
Source · Editorial brief grounded in 5 cited references ↓
- Specify the exact bone involved — talus or calcaneus — by name; 'foot bone' is insufficient for code selection.
- Confirm pathology type: bone cyst (e.g., unicameral, aneurysmal) or benign tumor, with imaging or pathology correlation.
- Document the autograft donor site (iliac crest or alternative) and the harvest technique in the operative note.
- Record dimensions or extent of the cystic or tumor lesion to support medical necessity.
- Note why autograft was selected over no-graft or allograft alternatives — relevant if payer audits code level.
- Include pre-op imaging (X-ray, MRI, or CT) in the record to establish diagnosis and operative planning.
Applicable modifiers
Modifiers commonly billed with this code.
Source · AMA CPT modifier descriptors · CMS NCCI Policy Manual
What this code covers
Source · Editorial summary grounded in 5 cited references ↓
28102 covers surgical removal or curettage of a bone cyst or benign tumor located in the talus or calcaneus, followed by packing the resulting defect with autogenous bone graft. The graft harvest — most commonly from the iliac crest — is bundled into 28102; do not separately report a graft-harvest code. This distinguishes 28102 from 28100 (no graft) and 28103 (allograft rather than autograft).
The 90-day global period means all routine post-op visits, wound checks, and cast/splint management through day 90 are bundled. Unrelated problems treated in that window require modifier 24 on the E&M. A staged or unplanned return to the OR for a related complication bills with modifier 78; an unrelated return uses modifier 79.
Site-of-service matters here. The HOPD and ASC facility payments differ substantially — see the Site of Service comparison table on this page. Most payers follow Medicare's bilateral reporting rule: one line with modifier 50 for professional claims, separate LT/RT lines for ASC facility claims.
RVU & reimbursement
Component RVUs and Medicare national rate. Actual payment varies by GPCI locality.
Source · CMS Physician Fee Schedule, RVU26A · January 2026
Work RVU vs. total RVU
The work RVU (7.72) is the surgeon's own effort — the figure physician pay and productivity targets are built on. The total RVU (17.46) adds practice overhead and malpractice, and is what drives the Medicare payment below.
| Work RVU | 7.72 |
| Practice expense RVU | 8.1 |
| Malpractice RVU | 1.64 |
| Total RVU | 17.46 |
| Medicare national rate | $583.18 |
| Global period | 90 days |
Payment by site of service
Medicare pays different rates by setting. HOPD typically pays substantially more than ASC for the same procedure.
Source · CMS OPPS Addendum B·ASC HCPCS payment rates·2026
| Setting | Medicare rate (national) |
|---|---|
Office (PFS non-facility) Procedure performed in physician's office | $583.18 |
HOPD (APC 5114) Hospital outpatient department | $7,413.38 |
ASC (PI J8) Ambulatory surgical center (freestanding) | $5,297.25 |
Common denial reasons
The recurring reasons claims for CPT 28102 get rejected.
Source · Editorial brief grounded in CMS NCCI edits, AAOS coding appeals, and cited references ↓
- Miscoded as 28100 (no graft) or 28103 (allograft) when autograft was used — code selection must match graft type documented.
- Graft harvest billed separately with an additional CPT code, triggering a bundling edit since harvest is included in 28102.
- Missing or vague pathology documentation — payers deny when the operative note doesn't distinguish cyst from benign tumor or confirm the talus/calcaneus site.
- Insufficient medical necessity support when pre-operative imaging is absent from the submitted record.
- Modifier 50 omitted on bilateral claims, causing a second unit to deny as a duplicate rather than a bilateral procedure.
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 5 cited references ↓
01What separates 28102 from 28100 and 28103?
02Can I bill separately for harvesting the iliac crest graft?
03How do I bill 28102 if the procedure is performed on both feet at the same encounter?
04What ICD-10 diagnoses support 28102?
05If I perform an E&M visit the day before surgery to obtain consent, is that billable?
06Does 28102 require inpatient admission, or is ASC appropriate?
07How should a return to the OR for a wound complication be billed within the global period?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CMS Physician Fee Schedule 2026
- 02aapc.comhttps://www.aapc.com/codes/cpt-codes/28102
- 03vsac.nlm.nih.govhttps://vsac.nlm.nih.gov/context/cs/codesystem/CPT/version/2024/code/28102/info
- 04cms.govhttps://www.cms.gov/files/document/04-chapter4-ncci-medicare-policy-manual-2025finalcleanpdf.pdf
- 05genhealth.aihttps://genhealth.ai/code/cpt4/28102-excision-or-curettage-of-bone-cyst-or-benign-tumor-talus-or-calcaneus-with-iliac-or-other-autograft-includes-obtaining-graft
Mira Scribe
Mira's AI scribe captures the bone involved (talus vs. calcaneus), graft type (autograft), and donor site from dictation — the three variables that differentiate 28102 from adjacent codes 28100 and 28103. It also flags when the operative note lacks defect dimensions or pathology characterization, preventing the documentation gaps that drive medical-necessity denials on audit.
See how Mira captures CPT 28102 documentation